|
161 |
The effects of HIV testing advocacy messages on test acceptance: a randomized clinical trial
Enthalten in BMC medicine Bd. 12, 6.11.2014, Nr. 1, date:12.2014: 1-8
|
|
|
|
162 |
The genome of the biting midge Culicoides sonorensis and gene expression analyses of vector competence for bluetongue virus
Enthalten in BMC genomics Bd. 19, 22.8.2018, Nr. 1, date:12.2018: 1-16
|
|
|
|
163 |
The genomic architecture of resistance to Campylobacter jejuni intestinal colonisation in chickens
Enthalten in BMC genomics Bd. 17, 18.4.2016, Nr. 1, date:12.2016: 1-18
|
|
|
|
164 |
The importance of pore throats in controlling the permeability of magmatic foams
Enthalten in Bulletin of volcanology Bd. 81, 14.8.2019, Nr. 9, date:9.2019: 1-17
|
|
|
|
165 |
The Role of Programmed Death-1 in Type 1 Diabetes
Enthalten in Current diabetes reports Bd. 21, 6.5.2021, Nr. 6, date:6.2021: 1-9
|
|
|
|
166 |
The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort
Enthalten in BMC medicine Bd. 17, 3.10.2019, Nr. 1, date:12.2019: 1-10
|
|
|
|
167 |
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer – a study protocol
Enthalten in BMC cancer Bd. 21, 18.11.2021, Nr. 1, date:12.2021: 1-11
|
|
|
|
168 |
Toward the validity of Prandtl's approximation in a boundary layer
Enthalten in Archive for rational mechanics and analysis Bd. 18, 1.1.1965, Nr. 1, date:1.1965: 1-13
|
|
|
|
169 |
Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK
Enthalten in BMC cancer Bd. 20, 17.7.2020, Nr. 1, date:12.2020: 1-9
|
|
|
|
170 |
Ultrasound thermometry in transparent and opaque fluids
Enthalten in Experiments in fluids Bd. 35, 28.6.2003, Nr. 2, date:8.2003: 152-158
|
|
Administration
